CorMedix Inc (CRMD) has introduced new options for trading, set to expire on August 15th. Investors can engage with a put contract at a $16.00 strike price, currently bidding at $0.90, effectively committing to buy the stock at $16.00 while realizing a cost basis of $15.10. This represents a 4% discount compared to the current trading price of $16.66.
On the call side, a $17.00 strike call contract is available, bidding at $1.00, providing a potential total return of 8.04% if exercised, with the stock currently at $16.66. The contract would expire worthless with a current probability of 45%. The implied volatility for the put and call contracts is 94% and 98%, respectively, while the trailing twelve-month volatility stands at 88%.
